Cargando…
Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia
BACKGROUND: Although most acute promyelocytic leukemia(APL) with low-intermediate risk could survive the induction treatment, early death still a big problem to have effects on overall survival in real world.This study aimed to analyze the clinical characteristics and possible predictors of early de...
Autores principales: | Wen, Jingjing, Xu, Fang, Zhou, Qiaolin, Shi, Lin, Liu, Yiping, Yue, Jing, Zhang, Ya, Liang, Xiaogong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515425/ https://www.ncbi.nlm.nih.gov/pubmed/36185183 http://dx.doi.org/10.3389/fonc.2022.895777 |
Ejemplares similares
-
Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia
por: Wen, Jingjing, et al.
Publicado: (2023) -
Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
por: Sun, Jianai, et al.
Publicado: (2020) -
Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk
por: Wen, Jingjing, et al.
Publicado: (2021) -
Analysis of early death in newly diagnosed acute promyelocytic leukemia patients
por: Xu, Fang, et al.
Publicado: (2017) -
Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)